WHO Approves Single-Dose CanSinoBIO COVID-19 Vaccine
The WHO approves the CanSinoBIO single-dose COVID-19 vaccine, Convidecia, for emergency use, highlighting its potential as both a primary immunization and heterologous booster, with the added advantage of storage at standard refrigeration temperatures.
January 2023
Methods to Reduce SARS-CoV-2 Transmission in Indoor Environments Explored
Various methods, including ventilation, filtration, and disinfection, are effective in reducing the concentration of SARS-CoV-2 particles in shared indoor air, offering practical strategies for mitigating viral transmission in indoor settings.
January 2023
Long-Term Health Outcomes Two Years After COVID-19 Hospitalization
Two years after hospitalization for COVID-19, half of the survivors continue to experience at least one symptom, highlighting the long-term health consequences of COVID-19 and the need for comprehensive post-acute care strategies.
January 2023
COVID-19 Pandemic Leads to Millions of Missed Cancer Screenings
The COVID-19 pandemic has resulted in millions of missed cancer screenings worldwide, raising concerns about delayed diagnoses and highlighting the need for catch-up screening initiatives to mitigate long-term consequences on cancer detection and treatment.
January 2023
Prolonged Hepatic Manifestations Observed in Pediatric COVID-19 Patients
Five pediatric patients who recovered from COVID-19 subsequently developed liver injury, highlighting the prolonged hepatic manifestations of the disease in children and emphasizing the need for continued monitoring and management.
January 2023
US COVID-19 Deaths Surpass One Million Amid Concerns Over Rising Cases
The US surpasses one million deaths from COVID-19 as daily case counts rise amidst the lifting of mask mandates and limited access to additional vaccine doses, highlighting ongoing challenges in pandemic control and mitigation efforts.
January 2023
Additional Approach Demonstrates Effectiveness of COVID-19 Vaccines in Reducing Pneumonia
Assessment of pneumonia chest CT scans provides an additional approach to demonstrating the effectiveness of different COVID-19 vaccines in reducing the risk of severe respiratory complications, complementing existing clinical trial data.
January 2023
CDC Recommends Booster Shots for Children Ages 5 to 11, along with Two Boosters for Adults over 50 and Immunocompromised Individuals
The CDC recommends booster shots for children ages 5 to 11, administered five months after their initial COVID-19 vaccination series, in addition to two booster doses for adults over 50 and immunocompromised individuals, aiming to enhance vaccine-induced immunity and protect vulnerable populations against severe COVID-19 outcomes.
January 2023
Steroid Prescriptions at Discharge Could Alleviate Chronic Inflammation in COVID-19 Survivors
Authors argue for the routine prescription of steroids at discharge for COVID-19 patients to mitigate chronic inflammation and reduce the risk of long-term complications associated with persistent immune dysregulation.
January 2023
